Nicholas Hoffman & Company, LLC. - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.

Quarter-by-quarter ownership
Nicholas Hoffman & Company, LLC. ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q1 2022$2,097,000
-1.3%
48,138
-0.1%
0.08%
+23.5%
Q4 2021$2,125,000
+12.9%
48,193
-2.2%
0.07%
-79.4%
Q3 2021$1,883,000
-4.9%
49,274
-0.9%
0.33%
-7.6%
Q2 2021$1,980,000
+12.9%
49,727
+1.2%
0.36%
+1.1%
Q1 2021$1,754,000
+30.2%
49,153
+34.2%
0.35%
+13.5%
Q4 2020$1,347,000
+22.2%
36,616
+25.1%
0.31%
+6.5%
Q3 2020$1,102,000
-9.4%
29,275
-1.8%
0.29%
-16.6%
Q2 2020$1,216,000
-0.7%
29,822
-7.7%
0.35%
-15.0%
Q1 2020$1,224,000
-30.7%
32,309
-14.0%
0.41%
-15.6%
Q4 2019$1,766,000
+9.1%
37,584
-0.9%
0.49%
-1.0%
Q3 2019$1,619,000
-43.7%
37,935
-47.3%
0.49%
+10.3%
Q2 2019$2,878,000
+87.9%
71,922
+96.2%
0.45%
-9.0%
Q1 2019$1,532,000
+16.1%
36,651
+6.2%
0.49%
+8.4%
Q4 2018$1,319,000
-62.2%
34,525
-60.2%
0.45%
-22.8%
Q3 2018$3,488,000
+100.5%
86,824
+101.2%
0.59%
-8.1%
Q2 2018$1,740,000
+1.8%
43,158
-1.4%
0.64%
-4.1%
Q1 2018$1,710,000
+127.7%
43,756
+106.6%
0.67%
+125.8%
Q4 2017$751,000
-43.4%
21,174
-35.2%
0.30%
-47.2%
Q3 2017$1,326,000
-3.5%
32,672
+2.6%
0.56%
-10.6%
Q2 2017$1,374,000
+6.4%
31,859
+4.1%
0.62%
+3.3%
Q1 2017$1,291,000
+38.4%
30,611
+27.4%
0.60%
+28.5%
Q4 2016$933,000
-19.7%
24,028
-10.8%
0.47%
-25.9%
Q3 2016$1,162,000
+0.1%
26,945
+0.6%
0.64%
-5.2%
Q2 2016$1,161,00026,7970.67%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Chubb Ltd 400,000$15,404,0006.76%
KAHN BROTHERS GROUP INC 833,315$32,090,960,0005.42%
Sio Capital Management, LLC 180,811$6,963,0004.06%
Sio Capital Management, LLC 170,000$6,547,0003.82%
OSTERWEIS CAPITAL MANAGEMENT INC 1,124,462$43,304,0003.12%
Keystone Financial Planning, Inc. 120,705$4,648,0003.04%
PVG Asset Management 186,553$7,184,156,0003.02%
P.R. Herzig & Co. Inc. 37,950$1,461,0002.98%
EQUITY INVESTMENT CORP 2,329,469$89,708,0002.89%
Sterneck Capital Management, LLC 114,816$4,422,0002.84%
View complete list of GLAXOSMITHKLINE PLC shareholders